Beta-alanine
carnosine precursor

Beta-alanine is an amino acid your body uses as a building block to make another substance: carnosine, which accumulates in the muscle. On its own, beta-alanine does little; its role is to serve as raw material. The more you take, the more carnosine you store, and it is carnosine that buffers the acidity generated in the muscle during intense effort.

Beta-alanine is not a stimulant: you do not feel it in the moment like a coffee before training. It works by accumulation, slowly filling the carnosine stores over several weeks.

Supplementing it raises muscle carnosine markedly: in the reference study, by around 59% after four weeks and 80% after ten (Hill et al., 2007). The response varies widely from one person to another. Through diet it is unfeasible: it would take more than a kilo of meat or fish a day to approach the amounts used in the studies.

The carnosine you make with beta-alanine works as a buffer inside the muscle. During intense effort the muscle grows more acidic, and that acidity is one of the things that forces you to slow down. Carnosine neutralizes part of that acidity, and that lets you sustain the intensity a little longer before fatigue sets in.

The improvement is small but real, and it is well measured: on average, around 2-3% in the efforts where it fits. That may seem little, and for most people it is; but in competition, a few seconds decide races.

In a very short, explosive effort (lifting a maximal load, a sprint of seconds) the muscle draws on an immediate energy reserve that generates almost no acidity. That is not beta-alanine’s terrain.

When the effort drags on without dropping in intensity, the muscle shifts to the glycolytic pathway and builds up hydrogen ions. That build-up acidifies the inside of the cell, and that acidity is one of the brakes that appear when you push hard: it contributes to the sensation that the muscle is seizing up. Carnosine captures those hydrogen ions and delays the fall in pH. It does not eliminate fatigue; it delays a little the moment it appears.

That is why the window of usefulness is so specific, one to four minutes: it is the range where the glycolytic pathway dominates and acidity is the limiting factor. Below a minute, the effort ends before acidity becomes the problem; in long efforts at an easy pace, the limit is the available fuel and oxygen, not acidity.

The benefit is clearer in tests of holding an effort to exhaustion than in tests of covering a fixed distance against the clock. Part of the difference may depend on the type of test rather than on an improvement that would be felt equally in competition.

The mechanism has a nuance the intermediate level does not capture: carnosine does not only buffer pH. It also improves calcium sensitivity in the muscle fiber (calcium is the signal that triggers each contraction), which could contribute to performance through a route distinct from buffering acidity. It is a secondary mechanism, less established than the buffering effect, and it is cited as a hypothesis, not as settled fact.

Here is the question that really matters, because beta-alanine is not equally useful for everything. It helps in intense efforts lasting, more or less, between one and four minutes. That is its terrain.

Sports that benefit include rowing, middle-distance swimming, middle-distance running in athletics, combat sports (judo, jiu-jitsu, taekwondo) and intermittent team sports, where you repeat sprints with short rests: soccer, basketball, volleyball.

And now what it does not do, which is just as important:

If your sport is not on the first list, it is honest to tell you that the benefit is concentrated in that one-to-four-minute range and thins out beyond it.

These sports share an effort profile: high intensity for one to four minutes, or intermittent efforts that repeat that demand. A rower in a 2,000, a 200 swimmer, a middle-distance runner, a judoka in a bout: they all live where acidity decides. In team sports the match lasts an hour, but what repeats are bursts, jumps and short sprints; the extra carnosine helps each repetition suffer a little less as the game goes on.

The case of pure strength causes confusion. Beta-alanine does not improve maximal strength, nor is that its function. There is a hypothesis that, by allowing you to train with a bit more volume before fatiguing, it might indirectly favor gains in muscle mass; but the trials that have tested it find no clear effect, and it is not a solid reason to take it with that goal.

The dose the evidence works with is 3.2 to 6.4 grams a day (the position of the International Society of Sports Nutrition, ISSN, places the effective range at 4–6 g/day; Trexler et al., 2015). Since the effect depends on gradually filling the carnosine stores, what matters is not what time you take it, but keeping it up daily for several weeks. The improvement begins to be noticeable from four weeks and settles in around ten or twelve.

Unlike other supplements, here the time of day is irrelevant: there is no need to take it before training. Whether you train that day or not, the effect depends on consistency, not on timing.

In the studies, the daily dose is usually split into doses of 1.6 grams or less. The reason is not efficacy but tolerance, and it has to do with the effect we describe just below.

The dosing in the literature is 3.2 to 6.4 g/day (the ISSN places the effective range at 4–6 g/day; Trexler et al., 2015), split into several doses. What governs the result is the total dose accumulated over weeks, not the moment of intake: that is why the time of day is irrelevant, unlike a stimulant such as caffeine.

Muscle carnosine rises markedly over the first four weeks and stabilizes around ten or twelve (Hill et al., 2007). On stopping, the decline is also slow: it takes weeks to return to baseline levels, not days.

Taking it with a carbohydrate-rich meal may favor accumulation slightly more, because insulin aids muscle uptake; it is a minor factor next to consistency, but a real one. The individual response varies widely: the rise in carnosine ranges from 60 to 200% between people, depending on fiber type, baseline diet and training. There is still no practical way to know in advance who will respond more.

The variability of response between people (a 60 to 200% rise in carnosine) is related to baseline carnosine content and to muscle fiber type. Someone starting from low levels (meat-free diets, a higher proportion of slow fibers) has more room to rise. There is still no practical, cheap marker to predict individual response before supplementing; measuring muscle carnosine requires a biopsy or spectroscopy, out of reach for most.

Beta-alanine has a characteristic, well-documented side effect: a tingling in the face, neck or hands, that appears some ten or twenty minutes after intake and clears on its own within an hour or an hour and a half. It is called paresthesia, and it is the only adverse effect that appears consistently in the studies. Its intensity depends above all on how much you take at once.

It is harmless. It is not an allergy and does not indicate that anything is wrong: beta-alanine briefly activates some skin receptors, with no further consequences.

It is worth dismantling a very widespread misunderstanding: the tingling does not mean the supplement is working. They are independent things. The effect on performance is cooked slowly, over weeks of accumulation; the tingling is an immediate reaction to the dose taken all at once. You can have a lot of tingling and little effect, or the other way around.

The studies observe that the tingling eases when the dose is split into smaller doses, when it is taken with some food, or with the so-called “sustained-release” formulas, designed precisely to release the beta-alanine more slowly.

The tingling has an identified mechanism, and it is not that of an allergy. Beta-alanine activates a specific receptor on the sensory neurons of the skin, MrgprD, which produces that tingling or prickling sensation. Since it is not allergic, it does not come with swelling or hives: it is a transient nerve activation.

It depends on the dose per intake: the studies observe that above about 800 milligrams at once in rapid release is when it tends to appear. Splitting the same daily dose into smaller intakes preserves the carnosine accumulation and reduces the peak that triggers the tingling; sustained-release formulas produce the same effect by design, by releasing the beta-alanine more slowly, and it is barely perceptible even at high doses.

Two combinations have backing, for different reasons.

Beta-alanine is not banned by the World Anti-Doping Agency (WADA). It is legal in competition and does not trigger a positive.

That said, there is a nuance that does not depend on beta-alanine itself, but on the supplement world in general: some products are contaminated with banned substances that do not appear on the label. That is why, for anyone competing under anti-doping control, there are independent certification seals (such as Informed Sport or NSF Certified for Sport) that test every batch before it reaches the market.

Beta-alanine does not appear on WADA’s list of prohibited substances, and there is no sign that this will change: it is an amino acid naturally present in the diet.

The real risk is not beta-alanine, but cross-contamination in the supplement industry. Independent audits have found, in the samples analyzed, far-from-negligible percentages of products that contained banned substances without declaring them on the label. For an athlete under testing that turns the choice of product into a serious matter, and it is the reason for third-party seals (Informed Sport, NSF Certified for Sport): they test batch by batch the guarantee the label does not give.

The “antioxidant” label that sometimes accompanies beta-alanine deserves a precise clarification, because it mixes two different things. The antioxidant and anti-glycation properties are described for carnosine, and come mostly from in vitro studies and animal models (Sale et al., 2013, a review). The leap that is not justified is to assume that supplementing beta-alanine (which raises intramuscular carnosine) translates into that benefit in people.

When it has been directly tested, the result has been negative. The controlled trials that have supplemented beta-alanine and measured oxidative stress markers have found no improvement (Smith et al., 2012, in young women; Gholami et al., 2022, in basketball players), and the De Brandt study made it especially clear: muscle carnosine rose and oxidative stress did not budge. The most plausible explanation is one of compartments: the carnosine that beta-alanine gains accumulates inside the muscle, while a systemic antioxidant effect would require concentrations in other tissues that this pathway does not reach.

In regulatory terms, EFSA has never approved an antioxidant claim for beta-alanine or for carnosine; in fact, it did not approve the performance claim either, having not considered the cause-effect relationship established with the data it assessed. The honest conclusion is simple: there is no basis for presenting beta-alanine as an antioxidant in humans.

The idea that beta-alanine influences mood or resistance to stress comes mostly from animal studies; in humans the evidence is scarce and inconclusive. The only relevant controlled trial, in older adults, found no overall cognitive improvement. Beyond a signal in a subgroup, there is no basis for taking it for cognitive purposes.

The same goes for the “antioxidant” label: that property belongs to carnosine and has been seen mostly in vitro and in animals (Sale et al., 2013, a review). When it has been tested in people, supplementing beta-alanine and measuring oxidative stress, the benefit has not appeared, not even when muscle carnosine rose. This is developed at the advanced level.

In healthy adults, beta-alanine has a good safety profile at the usual doses. Even so, it is worth being cautious:

As with any supplement, if you take medication or have a health condition, the prudent thing is to discuss it with your doctor before starting. The information on this page is educational and does not replace medical advice.

At research doses, the safety evaluations have found no relevant adverse effects in healthy adults beyond the tingling. Where information is lacking is in pregnancy, breastfeeding, children and adolescents: a danger has not been demonstrated, it is that it has not been studied, and given that gap the general recommendation is to avoid its use unless medically indicated.

This does not replace a professional’s assessment: with medication or a health condition, the sensible thing is to consult before starting.

Cognition and mood. The signal comes from animal models and some isolated subgroup; the only relevant controlled trial in humans found no overall cognitive improvement. There is no basis for cognitive use.

Hypertrophy and strength by an indirect route. It has been proposed that, by allowing you to train with a bit more volume before fatiguing, beta-alanine might indirectly favor gains in muscle mass. It is only a hypothesis: the trials that have tested it find no significant effect on lean mass versus placebo (Kern 2011, Kendrick 2008, Outlaw 2016), and there is no basis for taking it with that goal.

Predicting responders. We know the response varies from 60 to 200%, but there is no practical way to know in advance who will respond more.

Safety over the very long term and at high doses. The profile at the doses and durations studied is good; outside that range, the data are scarce.

Pregnancy, breastfeeding, childhood and adolescence. It is not that a risk has been seen: it is that it has not been studied. The absence of data is declared as such; what to do about that gap is a decision that rests with a healthcare professional.